Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chong-Jen Yu

Showing results (361-370 of 478) with videos related to

Pageof 48
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2011
Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cellsYing-Chih Liu, Hsin-Yung Yen, Chien-Yu Chen, et al.
ERJ Open Research|March 25, 2025
Randomised trial of assessing diagnostic yield in transbronchial biopsy with a guide sheathHao-Chun Chang, Yao-Wen Kuo, Ching-Kai Lin, et al.
Plos One|May 16, 2024
Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancerGee-Chen Chang, Jin-Yuan Shih, Chong-Jen Yu, et al.
Frontiers in Medicine|June 24, 2021
Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case ReportThomas Tao-Min Huang, Ying-Chun Chien, Chih-Hsien Wang, et al.
Open Forum Infectious Diseases|December 13, 2021
Subsequent Antituberculous Treatment May Not Be Mandatory Among Surgically Resected Culture-Negative Pulmonary Granulomas: A Retrospective Nationwide Multicenter Cohort StudyChe-Liang Chung, Wei-Chang Huang, Hung-Ling Huang, et al.
Critical Care Medicine|November 1, 2018
Increased Plasma Acetylcarnitine in Sepsis Is Associated With Multiple Organ Dysfunction and Mortality: A Multicenter Cohort StudyKuei-Pin Chung, Guan-Yuan Chen, Tzu-Yi Chuang, et al.
JTO Clinical and Research Reports|September 30, 2021
Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced <i>ALK</i>-Rearranged NSCLC: An ASCEND-4 Subgroup AnalysisDaniel S W Tan, Sarayut Geater, Chong-Jen Yu, et al.
Cancer Medicine|August 10, 2023
Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patientsSheng-Kai Liang, Chang-Wei Wu, Ching-I Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 5, 2013
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopyTzu-Hsiu Tsai, Ching-Yao Yang, Chao-Chi Ho, et al.
International Journal of Cancer|November 29, 2018
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutationsYen-Ting Lin, Jin-Shing Chen, Wei-Yu Liao, et al.
Pageof 48

Showing results (361-370 of 478) with videos related to

Sort By:
Pageof 48
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2011
Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cellsYing-Chih Liu, Hsin-Yung Yen, Chien-Yu Chen, et al.
ERJ Open Research|March 25, 2025
Randomised trial of assessing diagnostic yield in transbronchial biopsy with a guide sheathHao-Chun Chang, Yao-Wen Kuo, Ching-Kai Lin, et al.
Plos One|May 16, 2024
Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancerGee-Chen Chang, Jin-Yuan Shih, Chong-Jen Yu, et al.
Frontiers in Medicine|June 24, 2021
Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case ReportThomas Tao-Min Huang, Ying-Chun Chien, Chih-Hsien Wang, et al.
Open Forum Infectious Diseases|December 13, 2021
Subsequent Antituberculous Treatment May Not Be Mandatory Among Surgically Resected Culture-Negative Pulmonary Granulomas: A Retrospective Nationwide Multicenter Cohort StudyChe-Liang Chung, Wei-Chang Huang, Hung-Ling Huang, et al.
Critical Care Medicine|November 1, 2018
Increased Plasma Acetylcarnitine in Sepsis Is Associated With Multiple Organ Dysfunction and Mortality: A Multicenter Cohort StudyKuei-Pin Chung, Guan-Yuan Chen, Tzu-Yi Chuang, et al.
JTO Clinical and Research Reports|September 30, 2021
Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced <i>ALK</i>-Rearranged NSCLC: An ASCEND-4 Subgroup AnalysisDaniel S W Tan, Sarayut Geater, Chong-Jen Yu, et al.
Cancer Medicine|August 10, 2023
Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patientsSheng-Kai Liang, Chang-Wei Wu, Ching-I Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 5, 2013
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopyTzu-Hsiu Tsai, Ching-Yao Yang, Chao-Chi Ho, et al.
International Journal of Cancer|November 29, 2018
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutationsYen-Ting Lin, Jin-Shing Chen, Wei-Yu Liao, et al.
Pageof 48